专利检索 ap:("CHEMOCENTRYX, INC.") AND inv:"Christine Marie JANSON" 第 1 页

1.

发明申请
COMBINATION THERAPY USING A CHEMOKINE RECEPTOR 2 (CCR2) ANTAGONIST AND A PD-1/PD-L1 INHIBITOR 有权

公开(公告)号：US20230023075A1

公开(公告)日：2023-01-26

申请号：US17694829

申请日：2022-03-15

申请人： CHEMOCENTRYX, INC.

发明人： James J. CAMPBELL , Zhenhua MIAO , Thomas J. SCHALL , Israel CHARO , Shijie LI , Christine Marie JANSON , Rajinder SINGH , Karen EBSWORTH

IPC分类号： A61K31/536 , A61P35/00 , A61K31/165 , A61K31/357 , A61K45/06

摘要： The present disclosure is drawn to the combination therapy of a Chemokine Receptor 2 (CCR2) antagonist and a PD-1 and/or PD-L1 inhibitor in the treatment of cancer.